Insider Transactions in Q1 2024 at Enhabit, Inc. (EHAB)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 01
2024
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
578
-4.98%
|
$4,624
$8.81 P/Share
|
Mar 01
2024
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,764
+33.18%
|
$46,112
$8.81 P/Share
|
Mar 01
2024
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
772
-1.78%
|
$6,176
$8.81 P/Share
|
Mar 01
2024
|
Tanya Renee Marion Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,308
+27.3%
|
$130,464
$8.81 P/Share
|
Mar 01
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Open market or private sale
|
Direct |
634
-1.1%
|
$5,072
$8.81 P/Share
|
Mar 01
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
15,027
+20.63%
|
$120,216
$8.81 P/Share
|
Mar 01
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,327
-1.48%
|
$10,616
$8.81 P/Share
|
Mar 01
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,144
+16.83%
|
$145,152
$8.81 P/Share
|
Mar 01
2024
|
Dylan C Black General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-3.45%
|
$7,280
$8.81 P/Share
|
Mar 01
2024
|
Dylan C Black General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
14,942
+36.16%
|
$119,536
$8.81 P/Share
|
Mar 01
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,035
-1.43%
|
$8,280
$8.81 P/Share
|
Mar 01
2024
|
Julie Diane Jolley EVP of Home Health Operations |
BUY
Grant, award, or other acquisition
|
Direct |
18,144
+20.02%
|
$145,152
$8.81 P/Share
|
Mar 01
2024
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,591
-0.97%
|
$36,728
$8.81 P/Share
|
Mar 01
2024
|
Barbara Ann Jacobsmeyer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
114,302
+19.38%
|
$914,416
$8.81 P/Share
|
Feb 25
2024
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,063
-1.38%
|
$45,567
$9.49 P/Share
|
Feb 25
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
767
-1.06%
|
$6,903
$9.49 P/Share
|
Feb 25
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-0.77%
|
$2,997
$9.49 P/Share
|
Feb 25
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
614
-1.12%
|
$5,526
$9.49 P/Share
|
Feb 25
2024
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-1.26%
|
$3,114
$9.49 P/Share
|
Feb 24
2024
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
789
-0.21%
|
$7,101
$9.49 P/Share
|
Feb 24
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-0.28%
|
$1,845
$9.49 P/Share
|
Feb 24
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.42%
|
$1,629
$9.49 P/Share
|
Feb 24
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.33%
|
$1,629
$9.49 P/Share
|
Jan 11
2024
|
Barry P. Schochet Director |
BUY
Other acquisition or disposition
|
Direct |
7,325
+4.68%
|
$80,575
$11.49 P/Share
|
Jan 01
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,043
-1.86%
|
$10,430
$10.35 P/Share
|
Jan 01
2024
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,928
-2.63%
|
$99,280
$10.35 P/Share
|
Jan 01
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,043
-2.35%
|
$10,430
$10.35 P/Share
|